BioAge Labs
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
About BioAge Labs
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
Company Facts
- Headquarters
- Richmond
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- ipo
- Total Funding
- $408,900,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-21
- Website
- bioagelabs.com
Industries & Categories
Biopharma, Biotechnology, Life Science, Therapeutics
Social Links
Canonical: https://fsome.com/organization/bioage-labs-2901 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.